Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Pediatrix Medical Group Inc.

AMD stock gained on Wednesday alongside a boarder market rally and new analyst praise.


Why Is AMD Stock Up Today 4/8/26?

Spectral AI ( ($MDAI) ) has issued an announcement. Spectral AI, Inc. has appointed David McGuire as its Chief Financial Officer, effective May 4, ...

Spectral AI Appoints David McGuire as New CFO

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Takeda Pharmaceutical Co (TKPHF) and Omada Health, I...

Analysts’ Top Healthcare Picks: Takeda Pharmaceutical Co (TKPHF), Omada Health, Inc. (OMDA)

Semiconductor stocks are rallying today as easing tensions between the U.S. and Iran removed a key macro overhang and pushed investors back into ri...

‘Forget Nvidia,’ Says Top Investor as AMD Stock’s AI Moment Is Near

In a new note, five-star Bank of America ($BAC) analyst Vivek Arya raised the firm’s semiconductor revenue estimate to $1.3 trillion for 2026, whic...

AI Boom Forces BofA to Lift Chip Industry Outlook by $300 Billion

An update from Squirrel Media SA ( ($ES:SQRL) ) is now available. Squirrel Media S.A. has arranged a €22.5 million syndicated loan on competitive t...

Squirrel Media Secures €22.5 Million Syndicated Loan to Boost Content and Refinance Debt

Stocks were up on Wednesday due to a ceasefire agreement and tech sector rebound.


Morning News Wrap-Up 4/8/26: Today’s Biggest Stock Market Stories!

Alstom SA ( ($FR:ALO) ) has issued an update. Alstom, the French-listed rail specialist in smart and sustainable mobility solutions, designs and de...

Alstom Wins €295 Million European Signalling Contract

Shares of chipmaker Micron Technology ($MU) rallied 10.9% in pre-market trading today. UBS’ top analyst Timothy Arcuri raised his price target from...

Why Is Micron Stock Rallying 11% in Pre-Market Trading, 4/8/26?

Mizuho Securities analyst Uy Ear reiterated a Buy rating on Relmada Therapeutics yesterday and set a price target of $19.00. Ear covers the Healthc...

Mizuho Securities Remains a Buy on Relmada Therapeutics (RLMD)

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has shared an announcement. ResMed Inc. has disclosed a planne...

ResMed CEO Michael Farrell Plans Additional Insider Sale Under Rule 144

National Bank analyst Baltej Sidhu maintained a Buy rating on Hammond Power Solutions today and set a price target of C$235.00. Sidhu covers the In...

National Bank Sticks to Its Buy Rating for Hammond Power Solutions (HMDPF)

Cantor Fitzgerald analyst Jay Kornreich maintained a Buy rating on Modiv yesterday and set a price target of $18.00. The company’s shares closed ye...

Cantor Fitzgerald Remains a Buy on Modiv (MDV)

Citi analyst Nicholas Herman maintained a Hold rating on Amundi SA today and set a price target of €79.50. According to TipRanks, Herman is a 3-sta...

Citi Reaffirms Their Hold Rating on Amundi SA (0RDX)

Citigroup is heading into the first-quarter semiconductor earnings season with a cautious view, but it sees near-term upside in Advanced Micro Devi...

Why Citi Sees Upside in These 2 AI Semiconductor Stocks Ahead of Earnings

In a report released today, from Ord Minnett upgraded Medibank Private to a Buy, with a price target of A$5.10. Medibank Private has an analyst con...

Positive Report for Medibank Private (MDBPF) from Ord Minnett

MA Financial Group analyst Paul Hissey upgraded Genesis Minerals Limited to a Buy today and set a price target of A$8.40. According to TipRanks, Hi...

Genesis Minerals Limited (GMD) was upgraded to a Buy Rating at MA Financial Group

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has issued an update. ResMed reported its monthly CHESS Deposi...

ResMed Adjusts CDI and Share Balances Amid Transfers, Equity Issuance and Buybacks

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has provided an announcement. ResMed Inc. has disclosed that c...

ResMed Officer Sandercock Discloses Ongoing Insider Share Sales Under Rule 144

The latest announcement is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ). ResMed director Peter C. ...

ResMed Director Peter Farrell Plans Further Insider Share Sale Under Rule 144

The latest update is out from KMD Brands Limited ( ($AU:KMD) ). KMD Brands Limited has opened the retail component of its approximately NZ$58.5 mil...

KMD Brands Opens NZ$58.5m Retail Entitlement Offer to Australasian Shareholders

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Simulations Plus (SLP) and Mediwound (MDWD) with bul...

Analysts Offer Insights on Healthcare Companies: Simulations Plus (SLP) and Mediwound (MDWD)

The latest update is out from Medicus Pharma Ltd ( ($MDCX) ). Medicus Pharma has submitted an optimized Phase 2 clinical study protocol to the U.S....

Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market

Analysts have been eager to weigh in on the Technology sector with new ratings on Salesforce (CRM), MongoDB (MDB) and Diodes (DIOD). Salesforce (CR...

Analysts Conflicted on These Technology Names: Salesforce (CRM), MongoDB (MDB) and Diodes (DIOD)

Analysts have been eager to weigh in on the Technology sector with new ratings on Advanced Micro Devices (AMD) and Datadog (DDOG). Advanced Micro D...

Analysts Have Conflicting Sentiments on These Technology Companies: Advanced Micro Devices (AMD) and Datadog (DDOG)

In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Revolution Medicines, with a price target of $144.00. Accor...

LifeSci Capital Sticks to Its Buy Rating for Revolution Medicines (RVMD)

UBS analyst upgraded KMD Brands Limited to a Buy on April 3 and set a price target of N$0.14. KMD Brands Limited has an analyst consensus of Modera...

Positive Report for KMD Brands Limited (KMD) from UBS

MDB Capital Holdings, LLC Class A (($MDBH)) has held its Q4 earnings call. Read on for the main highlights of the call. MDB Capital Holdings, LLC C...

MDB Capital Holdings Bets on AI-Fueled Launch Surge

TSMC (TSM) has been on a tear, climbing 7% over the past week, driven by strong demand for AI processors and growing optimism from analysts. Invest...

Why Is Wall Street Bullish on TSMC Stock (TSM) Ahead of Q1 Earnings?

Jefferies analyst Edison Lee maintained a Buy rating on China Mobile on April 3 and set a price target of HK$97.46. According to TipRanks, Lee is a...

Jefferies Sticks to Their Buy Rating for China Mobile (0941)

NMDC Limited ( ($IN:NMDC) ) has provided an announcement. NMDC Limited has revised its iron ore prices effective 5 April 2026, setting Baila Lump (...

NMDC Resets Iron Ore Prices Effective 5 April 2026

In a report released yesterday, from China Renaissance maintained a Buy rating on Meituan, with a price target of HK$120.00. In addition to China R...

China Renaissance Reaffirms Their Buy Rating on Meituan (MPNGF)

OncoCyte Corp (($IMDX)) has held its Q4 earnings call. Read on for the main highlights of the call. OncoCyte’s latest earnings call carried a cauti...

OncoCyte Earnings Call: GraftAssureDx Drives Pivot

Advanced Micro Devices ( ($AMD) ) has been popular among investors this week. Here is a recap of the key news on this stock. Advanced Micro Devices...

Advanced Micro Devices Ignites AI Hopes as Analysts Pile In

In a report released yesterday, Jonathan Sharp from J.P. Morgan maintained a Buy rating on Genesis Minerals Limited, with a price target of A$7.90....

Genesis Minerals Limited (GMD) Gets a Buy from J.P. Morgan

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medtronic (MDT), Pharvaris (PHVS) and Amgen (AMGN) w...

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Pharvaris (PHVS)

REPRO-MED Systems ( ($KRMD) ) has shared an announcement. On March 30, 2026, KORU Medical Systems, Inc. amended its existing $10 million credit fac...

REPRO-MED Systems Amends Credit Facility to Enhance Flexibility

The latest update is out from biote ( ($BTMD) ). On April 3, 2026, Biote Corp. posted an updated investor presentation for April 2026 on its websit...

Biote Updates April 2026 Investor Presentation on Growth

Medallion Financial ( ($MFIN) ) has provided an update. As of March 31, 2026, approximately 3% of Medallion Financial Corp.’s consolidated borrowin...

SBA Default on Debentures Puts Medallion Financial Under Review

RBC Capital analyst Jackie Moody maintained a Hold rating on KMD Brands Limited on March 31 and set a price target of N$0.15. The company’s shares ...

KMD Brands Limited (KMD) Receives a Hold from RBC Capital

First Shanghai Securities analyst maintained a Buy rating on China Mobile yesterday and set a price target of HK$108.00. Currently, the analyst con...

China Mobile (0941) Receives a Buy from First Shanghai Securities

Advanced Micro Devices ($AMD), a leading maker of high-performance chips, just earned a new upgrade from Wall Street as strong AI demand continues ...

‘Buy AMD Stock,’ Says Top Analyst as Strong Data Center Demand Drives Upgrade

Madoro Metals Corp ( ($TSE:MDM) ) has shared an update. Madoro Metals Corp. and Narrow River Resources are advancing a proposed reverse takeover th...

Madoro Metals Advances Reverse Takeover Process With Narrow River Resources

Kamada Ltd (($IL:KMDA)) has held its Q4 earnings call. Read on for the main highlights of the call. Kamada Ltd’s latest earnings call carried an up...

Kamada Ltd Earnings Call Signals Confident Growth Path

Lifemd, Inc. (($LFMD)) has held its Q4 earnings call. Read on for the main highlights of the call. LifeMD’s latest earnings call struck an upbeat t...

LifeMD Earnings Call Highlights Aggressive Growth Push

AMD stock was up after the company’s CPU and GPU market shares gained on Steam in March.


AMD Stock Jumps Alongside Gains In the March 2026 Steam Hardware Survey

The latest announcement is out from Mediwound ( ($MDWD) ). On April 2, 2026, MediWound reported that its North American partner Vericel secured a t...

MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid

Investors will find the hottest stock market stories ready to go in our daily wrap-up for Thursday.


Morning News Wrap-Up 4/2/26: Today’s Biggest Stock Market Stories!

The latest announcement is out from Baronsmead Second Venture ( ($GB:BMD) ). Baronsmead Second Venture Trust PLC reported that non-executive direct...

Baronsmead Second Venture Trust Directors Reinvest Dividends Into Shares

The U.S.-Iran war and elevated oil prices due to supply disruption in the Middle East continue to weigh on global stock markets. Investors looking ...

Best ETFs to Invest In, According to AI Analyst, 4/2/2026

Baronsmead Second Venture ( ($GB:BMD) ) has provided an announcement. Baronsmead Second Venture Trust PLC has allotted 12,370,324 new ordinary shar...

Baronsmead Second Venture Trust Extends Share Offer and Issues New Equity Ahead of Tax Relief Cut

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TransMedics Group (TMDX) and Dexcom (DXCM) with bull...

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Dexcom (DXCM)

In a report released on March 31, Luigi Tramontana from Kepler Capital maintained a Hold rating on Banca Monte dei Paschi di Siena SPA, with a pric...

Banca Monte dei Paschi di Siena SPA (0RK6) Gets a Hold from Kepler Capital

UBS analyst maintained a Buy rating on Meituan on March 31 and set a price target of HK$128.00. The company’s shares closed last Tuesday at HK$82.9...

UBS Sticks to Their Buy Rating for Meituan (MPNGF)

AMD stock gained on Wednesday after it was added to Well Fargo’s Q2 Tactical Ideas List.


AMD Stock Rallies as Wells Fargo Heaps Praise on the Chipmaker

HeraMED Ltd. ( ($AU:HMD) ) has issued an announcement. HeraMED Ltd. has applied to the ASX for quotation of 38,699,315 new fully paid ordinary shar...

HeraMED Seeks ASX Quotation for 38.7 Million New Shares

Medalist Diversified REIT ( ($MDRR) ) has provided an update. On March 30, 2026, Medalist Diversified REIT closed the $24.1 million sale of the 134...

Medalist Diversified REIT Announces Quarterly Dividend After Disposals

The latest announcement is out from Melco International ( ($HK:0200) ). Melco International has formalised detailed terms of reference for its Audi...

Melco International Strengthens Governance With Formal Audit Committee Mandate

Melco International ( ($HK:0200) ) just unveiled an update. Melco International has formalized the terms of reference for its Nomination and Corpor...

Melco International Strengthens Board Oversight With New Nomination and Governance Mandate

Stocks climbed today alongside earnings reports, analysts updates, and other economic happenings.


Morning News Wrap-Up 4/1/26: Today’s Biggest Stock Market Stories!

TherapeuticsMD ( ($TXMD) ) has released a notification of late filing. TherapeuticsMD, Inc. has filed a Form 12b-25 to notify investors of a brief ...

TherapeuticsMD Explains Brief Delay In Annual Filing

An update from Midland Exploration ( ($TSE:MD) ) is now available. Midland Exploration, in partnership with SOQUEM, is advancing its Malaco Mountai...

Midland and SOQUEM to Launch IP Survey at High-Grade Malaco Mountain Discovery

GeoPark ( ($GPRK) ) has shared an announcement. On March 31, 2026, GeoPark announced it had filed its Form 20-F for the fiscal year ended December ...

GeoPark Files 2025 Form 20-F With SEC, Expands Investor Access to Annual Report

Liberty Global LiLAC ( ($LILA) ) just unveiled an update. On March 27, 2026, Liberty Latin America Ltd. entered into an exchange agreement with its...

Liberty Latin America CEO Executes Share Class Exchange

Citic Securities analyst maintained a Buy rating on Meituan on March 30 and set a price target of HK$115.00. The company’s shares closed yesterday ...

Citic Securities Keeps Their Buy Rating on Meituan (MPNGF)

Nu-Med Plus ( ($NUMD) ) has released a notification of late filing. Nu-Med Plus, Inc. has filed a Form 12b-25 to notify investors that it will be l...

Nu-Med Plus Delays Annual 10-K Filing

MediXall Group ( ($MDXL) ) has released a notification of late filing. MediXall Group, Inc. has filed a Form 12b-25 to notify investors that it wil...

MediXall Group Delays Annual SEC Filing

Mountain Valley MD ( ($TSE:MVMD) ) has shared an update. Mountain Valley MD Holdings plans a non-brokered private placement of up to 80,000,000 uni...

Mountain Valley MD to Raise $2 Million and Wipe Out Debt via Equity Deals

Electrolux AB ( ($SE:ELUX.B) ) just unveiled an announcement. Electrolux Group will cease manufacturing operations at its factory in Santiago, Chil...

Electrolux to Close Chile Factory, Booking SEK 0.5 Billion Restructuring Charge

The latest update is out from Melco International ( ($HK:0200) ). Melco International reported net revenues of HK$40.24 billion for 2025, up 11.2% ...

Melco International Swings to 2025 Profit on Strong Casino Recovery

Baronsmead Second Venture ( ($GB:BMD) ) just unveiled an update. Baronsmead Second Venture Trust plc has sold 1,310,000 of its own ordinary shares ...

Baronsmead Second Venture Trust Releases Treasury Shares, Updates Voting Rights

The latest stock market stories for Tuesday are ready to go in the daily wrap-up.


Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medicus Pharma Ltd (MDCX) and Butterfly Network (BFL...

Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Butterfly Network (BFLY)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Flex (FLEX) and Advanced Micro Devices (AMD) with bu...

Analysts’ Top Technology Picks: Flex (FLEX), Advanced Micro Devices (AMD)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Micron (MU) and Advanced Micro Devices (AMD) with bu...

Analysts Offer Insights on Technology Companies: Micron (MU) and Advanced Micro Devices (AMD)

Midas Minerals Limited ( ($AU:MM1) ) has provided an update. Midas Minerals has scheduled its Annual General Meeting for 27 May 2026, at which shar...

Midas Minerals Sets AGM Date and Director Nomination Deadline

Meridian Energy Limited ( ($MDDNF) ) has issued an announcement. Meridian Energy Limited has issued A$400 million of fixed rate green medium term n...

Meridian Raises A$400m in Oversubscribed Green Medium Term Note Issue

Nomura analyst maintained a Hold rating on Meituan on March 29 and set a price target of HK$92.00. The word on The Street in general, suggests a St...

Nomura Remains a Hold on Meituan (MPNGF)

Mediwound ( ($MDWD) ) has shared an announcement. On March 30, 2026, MediWound filed a Form 6-K announcing it had published proxy materials and not...

MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus

An update from KMD Brands Limited ( ($AU:KMD) ) is now available. KMD Brands Limited has had trading in its shares voluntarily suspended on both th...

KMD Brands Suspends Trading to Execute NZ$65m Capital Raising

Medicus Pharma Ltd ( ($MDCX) ) has provided an update. Medicus Pharma reported that key opinion leader and principal investigator Dr. Babar Rao has...

Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate

Stocks have pulled back since the Iran conflict began, yet the decline has been modest. The S&P 500 ($SPY) is down about 7%, which is not far from ...

Wall Street Raises Earnings Estimates Despite War Fears as NVDA, AMD, and SPY Show Resilience

Analysts fell to the sidelines weighing in on Dole (DOLE) and Nomad Foods (NOMD) with neutral ratings, indicating that the experts are neither bull...

Analysts Offer Insights on Consumer Goods Companies: Dole (DOLE) and Nomad Foods (NOMD)

China Merchants Securities analyst maintained a Buy rating on Meituan yesterday and set a price target of HK$135.60. In addition to China Merchants...

Meituan (MPNGF) Receives a Buy from China Merchants Securities

Macquarie analyst Adam Baker maintained a Buy rating on Genesis Minerals Limited today and set a price target of A$9.60. Baker covers the Basic Mat...

Macquarie Sticks to Its Buy Rating for Genesis Minerals Limited (GMD)

An announcement from Emyria Ltd ( ($AU:EMD) ) is now available. Emyria has called a general meeting of shareholders to be held in Perth on 1 May 20...

Emyria moves to digital distribution for upcoming shareholder meeting

HeraMED Ltd. ( ($AU:HMD) ) has shared an update. HeraMED Limited has scheduled its Annual General Meeting for 21 May 2026 at 9:00am AEST, and has s...

HeraMED Sets May 2026 AGM Date and Deadline for Director Nominations

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Incyte (INCY) and Veradigm (MDRX) with bullish senti...

Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Veradigm (OtherMDRX)

Technology stocks, including stocks of chip companies, have been under pressure recently amid geopolitical tensions in the Middle East. Several inv...

MU vs. NVDA vs. AMD: Which Chip Stock Has the Best Upside Potential, According to Wall Street?

KMD Brands Limited ( ($AU:KMD) ) has issued an update. KMD Brands has secured regulatory approval for a voluntary suspension of trading in its ordi...

KMD Brands Suspends Trading as It Finalises Capital Raise and Refinancing

Cathie Wood’s ARK Invest&nbsp;ETFs&nbsp;(exchange-traded funds) continued cutting exposure to big tech on Friday, March 27, 2026, as the firm locke...

NVDA, META, TSLA, AMD: Why Cathie Wood Is Trimming These Big Tech Stocks

While many big tech stocks have had a weak start to 2026, Taiwan Semiconductor Manufacturing Company ($TSM) is standing out. The company has stayed...

This Chip Stock Is the Only Trillion-Dollar Winner in the 2026 Tech Slump

Markets React to Oil, Risk, and Rotation U.S. stocks moved lower last week as war risk and rising oil prices weighed on sentiment. The S&P 500 (SPX...

The Week That Was, The Week Ahead: Macro and Markets, Mar. 29

In a report released yesterday, from CSC Financial maintained a Buy rating on Meituan, with a price target of HK$113.37. In addition to CSC Financi...

CSC Financial Remains a Buy on Meituan (MPNGF)

GF Securities analyst maintained a Buy rating on Meituan yesterday and set a price target of HK$111.37. In addition to GF Securities, Meituan also ...

Meituan (MPNGF) Gets a Buy from GF Securities

Advanced Micro Devices Stock Wobbles as AI Demand Surges

Traders can read the latest stock market happenings in our daily wrap-up.


Morning News Wrap-Up: 3/27/26: Today’s Biggest Stock Market Stories

In a report released yesterday, from Huatai Securities maintained a Buy rating on Meituan, with a price target of HK$121.40. The company’s shares c...

Current Quarter	$0.34	Next Quarter	$0.53
Current Year	$2.05	Next Year	$2.07
QoQ Growth	+55.9%	YoY Growth	+1.0%
3Y EPS CAGR	-40.5%	Target Price	$21.33
Consensus	Buy	Upside	-0.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MD	$21.46	-1.29%	494.84K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MD	$21.46	-1.3%	494.84K
3
4
5
6

MD

MD

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Pediatrix Medical Group Inc. Data in Excel

Get Pediatrix Medical Group Inc. Data in Excel